(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

DIALYSIS AT SEA CRUISES

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

DIALYSIS AT SEA CRUISES

ST13

US500000087817652

Class

39

Filing

87817652

Registration

5973615

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

34

Latest update

03/18/2026

Trademark type

Combined

Nice classes

39

Filing date

03/02/2018

Registration date

01/28/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/17/2026

Last transaction

03/18/2026

Responsible office

United States Patent and Trademark Office

Status code

702

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

01/14/2005

First use in commerce

01/14/2005

Drawing code

3

Owner type

03

Owner location

Land O Lakes, FL, US

Examiner

HWANG, JOHN C B

Current location

Historical data usage

Mark description

The mark consists of Stylized lettering of "Dialysis at Sea Cruises" with "Cruises" in all capital stylized lettering with a forward ship design to the right of the lettering with wave designs above "Cruises" and to the left of "at Sea".

Holders and representatives

Holders

LTBS, Inc.
LTBS, Inc.

Representatives

Randy K. Sterns BUSH ROSS, P.A.

Technical classification

Nice Classes

Class 39

Vienna Codes

No Vienna codes available.

Goods and services

Class 39

Travel planning and coordinationfor recreational and education sea cruises undertaken by passengers suffering from renal disease or failure

Publications

History of USPTO decisions and trademark events.

34 publications found

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

03/17/2026

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

03/17/2026

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

03/16/2026

E815

TEAS SECTION 8 & 15 RECEIVED

12/12/2025

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

01/28/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

01/28/2020

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

12/27/2019

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

12/26/2019

SUPC

STATEMENT OF USE PROCESSING COMPLETE

12/17/2019

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

12/17/2019

IUAF

USE AMENDMENT FILED

12/11/2019

EISU

TEAS STATEMENT OF USE RECEIVED

12/11/2019

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

06/11/2019

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

04/16/2019

PUBO

PUBLISHED FOR OPPOSITION

04/16/2019

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/27/2019

ALIE

ASSIGNED TO LIE

03/08/2019

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/15/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/14/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/13/2019

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

02/13/2019

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

08/13/2018

GNFR

FINAL REFUSAL E-MAILED

08/13/2018

CNFR

FINAL REFUSAL WRITTEN

08/13/2018

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/10/2018

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/09/2018

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/09/2018

GPRN

NOTIFICATION OF PRIORITY ACTION E-MAILED

06/15/2018

GPRA

PRIORITY ACTION E-MAILED

06/15/2018

CPRA

PRIORITY ACTION WRITTEN

06/15/2018

DOCK

ASSIGNED TO EXAMINER

06/14/2018

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

03/10/2018

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

03/09/2018

NWAP

NEW APPLICATION ENTERED

03/06/2018

Continuous trademark protection

Get notified about every new filing that threatens DIALYSIS AT SEA CRUISES or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.